Fosun Pharmaceutical

US-China trade war gets mixed reviews from Chinese attendees at BIO

Some Chinese attendees said they are not yet affected but maybe while others said they weren't affected and that the trade impasse was likely to turn the attention of the biotech companies to Europe. Chinese pharma wouldn't be affected.

By Alaric DeArment

Diagnostics, Devices & Diagnostics

Say hello to Butterfly Network, digital health’s newest unicorn

The portable ultrasound company raised a $250 million Series D financing round led by financial services Fidelity at a $1.25 billion valuation.

By Kevin Truong

With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?

Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.